Legend Biotech (LEGN) Cash from Investing Activities Growth (1y) (2020 - 2025)
Legend Biotech (LEGN) Cash from Investing Activities Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -114.28% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 826.39% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -674.01% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -166.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 826.39% |
| Sep 30, 2025 | -106.08% |
| Jun 30, 2025 | 76.21% |
| Mar 31, 2025 | 164.78% |
| Dec 31, 2024 | -121.57% |
| Sep 30, 2024 | 257.40% |
| Jun 30, 2024 | -471.67% |
| Mar 31, 2024 | -2,570.98% |
| Dec 31, 2023 | 620.15% |
| Sep 30, 2023 | -263.48% |
| Jun 30, 2023 | -4,807.27% |
| Mar 31, 2023 | 106.90% |
| Dec 31, 2022 | 59.82% |
| Sep 30, 2022 | 221.03% |
| Jun 30, 2022 | 101.53% |
| Mar 31, 2022 | -1,255.69% |
| Dec 31, 2021 | -706.75% |
| Sep 30, 2021 | -80.26% |
| Jun 30, 2021 | -1,731.01% |
| Mar 31, 2021 | 1.99% |